Ignite Creation Date:
2025-12-24 @ 4:54 PM
Ignite Modification Date:
2026-01-04 @ 2:27 PM
Study NCT ID:
NCT00250250
Status:
COMPLETED
Last Update Posted:
2011-05-20
First Post:
2005-11-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG
Sponsor:
Ferring Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-10
Start Date Type:
None
Primary Completion Date:
2006-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-08
Completion Date Type:
ACTUAL
First Submit Date:
2005-11-07
First Submit QC Date:
None
Study First Post Date:
2005-11-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-05-19
Last Update Post Date:
2011-05-20
Last Update Post Date Type:
ESTIMATED